about
Anti-apoptotic protein TCTP controls the stability of the tumor suppressor p53Major clinical research advances in gynecologic cancer in 2013Lower extremity edema in patients with early ovarian cancerMajor clinical research advances in gynecologic cancer in 2014The Effect of Breastfeeding Duration and Parity on the Risk of Epithelial Ovarian Cancer: A Systematic Review and Meta-analysisComparison of the efficacy between topotecan- and belotecan-, a new camptothecin analog, based chemotherapies for recurrent epithelial ovarian cancer: a single institutional experience.Phase I clinical trial of alternating belotecan and oral etoposide in patients with platinum-resistant or heavily treated ovarian cancer.Phase I study of oral ridaforolimus in combination with paclitaxel and carboplatin in patients with solid tumor cancers.Epstein-Barr virus-transformation of B-cell lines in ovarian cancer patients: feasibility of genomic storage for unlimited use.Survival outcomes after extensive cytoreductive surgery and selective neoadjuvant chemotherapy according to institutional criteria in bulky stage IIIC and IV epithelial ovarian cancer.Alteration in lipid and protein profiles of ovarian cancer: similarity to breast cancer.Thioridazine inhibits angiogenesis and tumor growth by targeting the VEGFR-2/PI3K/mTOR pathway in ovarian cancer xenograftsPerformance of papanicolaou testing and detection of cervical carcinoma in situ in participants of organized cervical cancer screening in South Korea.Completeness of pedigree and family cancer history for ovarian cancer patientsThe antihypertension drug doxazosin suppresses JAK/STATs phosphorylation and enhances the effects of IFN-α/γ-induced apoptosis.Cervical adenocarcinoma in situ with negative conization margin: negligible or not?Prediction of a high-risk group based on postoperative nadir CA-125 levels in patients with advanced epithelial ovarian cancerMulti-dimensional TOF-SIMS analysis for effective profiling of disease-related ions from the tissue surface.Population attributable risks of modifiable reproductive factors for breast and ovarian cancers in Korea.Health Behaviors and Associated Sociodemographic Factors in Cervical Cancer Survivors Compared with Matched Non-Cancer Controls.Thioridazine induces apoptosis by targeting the PI3K/Akt/mTOR pathway in cervical and endometrial cancer cellsControversies in the management of endometrial cancer: a survey of the Korean Gynecologic Oncology Group.Pelvic exenteration for recurrent cervical cancer: ten-year experience at National Cancer Center in KoreaIncidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012Single nucleotide polymorphism: a new risk factor for endometrial cancer?Intraoperative image-guided surgery for ovarian cancerThe benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.Second Primary Cancer after Diagnosis and Treatment of Cervical Cancer.Cost-utility analysis for platinum-sensitive recurrent ovarian cancer therapy in South Korea: results of the polyethylene glycolated liposomal doxorubicin/carboplatin sequencing modelThe association of pre-conization high-risk HPV load and the persistence of HPV infection and persistence/recurrence of cervical intraepithelial neoplasia after conization.Allogeneic blood transfusion given before radiotherapy is associated with the poor clinical outcome in patients with cervical cancer.Laparoscopic and laparotomic staging in stage I epithelial ovarian cancer: a comparison of feasibility and safety.Experiences of pretreatment laparoscopic surgical staging in patients with locally advanced cervical cancer: results of a prospective studyInterleukin-1 beta-511 polymorphism and risk of cervical cancer.Prognostic factors of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancerRole of high risk-human papilloma virus test in the follow-up of patients who underwent conization of the cervix for cervical intraepithelial neoplasia.Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010.The clinical significance of hepatic parenchymal metastasis in patients with primary epithelial ovarian cancer.Nadir CA-125 level is an independent prognostic factor in advanced epithelial ovarian cancer.The utility of multi-detector computed tomography in the diagnosis of malignant pleural effusion in the patients with ovarian cancer.
P50
Q24307469-E48A9461-8123-44C7-BD4D-AE3F83F7795FQ24562146-34B16DAB-4801-411C-BB7D-2D65279EC904Q26859231-C5870475-F102-4B90-8C78-BBE45746E5A9Q26992183-846D1AE6-BFDB-45CE-BA06-5A4B45925BB8Q28066985-26D41480-16C8-45FF-8158-7CA7B0A746F6Q33388360-46DD6764-7748-4A83-9EDF-2338E819E5A1Q33398670-E5824A52-13AF-42DE-AC09-40507674EEDFQ33442539-10DA2B8A-6D68-4E8A-8B08-5D73B3596602Q33561012-24833000-7386-469E-BA1F-6655B7C5CBAAQ33735142-DB16A57F-2C1C-48F3-80FD-D79150F2598FQ34085176-A53CF696-C7B7-4EBC-A278-4AF033EF5469Q34104095-B9B5C5E2-F15A-4D21-91DB-B473DDA0CE92Q34243766-68751C40-CCB6-4648-ADAF-33C81F05E1DBQ34330356-3E623669-9205-4AAB-8478-1ACF1B4013BBQ34786660-465637D0-EDA5-4712-ABBD-1B8885D71B3DQ34990449-E68200C4-D195-49CE-A525-3A17F2BAB513Q35663653-904F42BE-3098-45D3-BA57-814081277508Q35687481-2ADC26DE-B1AF-4171-983E-FBE4D31BEBDCQ35886099-A9AA465D-E343-4176-A7AF-46A4ECEE6464Q36105026-8D72FD26-139C-4DE0-99CE-FDDF9A11332DQ36147137-5B7B84D8-2122-4D4F-B24D-14B26A36A793Q36205594-C2E6FCEC-BF44-4991-A2B5-5E41334D0C18Q36313275-3972AFBE-1337-49F8-A04D-14FE028A612DQ36415295-E80A6A53-0F2C-4CD7-813D-C0247398294EQ36429478-D590EC76-DD6A-4336-A4D0-FD8B6DB2ADCBQ36429744-A8C5028D-1C89-4A3D-AF3A-25FC7AF0DF58Q36534351-39C99106-D514-4021-B42E-1A03FCD07B81Q36832186-4136F16E-C36B-47DB-B356-E5F9A4AF7B18Q36996565-3709EF9E-C5E4-4438-AA9E-18686447CB32Q37051694-D0466AED-6182-44C4-B770-8CFDD4EFD2F3Q37065182-1520349C-DB98-4BBB-B39F-3769BBF55260Q37088476-985CDDA0-3CDD-4131-B758-11E593E71138Q37177643-547B428A-7E5D-44A2-8D5F-7FA2DE212DB9Q37220168-7DDF7A3A-E079-4C6E-9D03-DF43E8FA9A08Q37248501-5C191052-2F9B-4D19-877B-E6FE601E1614Q37248554-A18EDE5A-05A7-4E14-8764-F60795F66E15Q37249280-FA29DB7D-FEBE-4926-9F71-8E2CDC130FE9Q37326018-D36E18B8-E344-4008-BCD1-73BEBA078FC2Q37408202-9D661801-A085-4A3A-B2C3-C9E345F637ADQ37501110-C0E22F97-75A7-42C6-A386-6A5613AFAB91
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sokbom Kang
@ast
Sokbom Kang
@en
Sokbom Kang
@es
Sokbom Kang
@nl
Sokbom Kang
@sl
type
label
Sokbom Kang
@ast
Sokbom Kang
@en
Sokbom Kang
@es
Sokbom Kang
@nl
Sokbom Kang
@sl
prefLabel
Sokbom Kang
@ast
Sokbom Kang
@en
Sokbom Kang
@es
Sokbom Kang
@nl
Sokbom Kang
@sl
P106
P1153
8574019000
P21
P31
P496
0000-0002-8428-9555